Fletta eftir höfundi "Löve, Þorvarður Jón"

Atriði 1-2 af 2

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

Palsson, Olafur; Löve, Þorvarður Jón; Gunnarsdóttir, Anna Ingibjörg; Gunnarsson, Pétur Sigurður; Rúnarsdóttir, Eydís Erla; Krogh, Niels Steen; Gudbjornsson, Bjorn (BMJ, 2019-07)

Objectives To determine in a retrospective cohort whether patients with psoriatic arthritis (PsA) who would not have fulfilled the inclusion criteria for randomised controlled trials (RCTs) for the TNF inhibitor (TNFi) chosen for their treatment (excl) ...
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents

Ólafsson, Sigurður; Tyrfingsson, Þórarinn; Rúnarsdóttir, Valgerður; Bergmann, Óttar Már; Hansdóttir, Ingunn; Björnsson, Einar Stefán; Jóhannsson, B.; Sigurðardóttir, Bryndís; Fridriksdóttir, R. H.; Löve, Arthur; Hellard, M.; Löve, Þorvarður Jón; Gudnason, Thorarinn; Heimisdottir, María; Gottfredsson, Magnus (Wiley, 2018-03-07)

A nationwide programme for the treatment of all patients infected with hepatitis C virus (HCV) was launched in Iceland in January 2016. By providing universal access to direct‐acting antiviral agents to the entire patient population, the two key aims ...

Atriði 1-2 af 2

Leita